U.S. Cord Blood Banking Market Size Worth $49.1 Billion By 2025

December 2017 | Report Format: Electronic (PDF)

The U.S. cord blood banking market is expected to reach USD 49.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing awareness regarding long term benefits of cord blood storage, increasing number of service providers, reduction in cost involved in storage, and growing investment in public banking are the factors driving the market growth in the country.

The U.S. cord blood banking market captures a significant share of the global cord blood banking industry. Factors such as high adoption rate for advanced technologies, growing per capita income, and increasing number of storage service providers can be attributable to the largest market share.

Growing applications of cord blood in the treatment of several chronic disorders is expected to fuel the market. Currently cord blood is approved for usage in around 80 diseases. These disease include degenerative disorders such as cancers, immunodeficiency related disorders, and bone marrow disorders. Growing prevalence of such diseases and need for effective therapeutic treatments are expected to boost the number of units stored.  A large number of ongoing clinical trials in phase II, III, and IV are showing a potential growth opportunity in the near future.

 To request a sample copy or view summary of this report, click the link below:

Further Key Findings from the Report Suggest:

  • Private banking currently captures the largest revenue share and is expected to dominate the market throughout the forecast period

  • Large number of parents opting for private banking, high prices involved in collection, transport and storage, and increasing number of these type of service provides are the prime factors expected to result in swift growth of the segment during the forecast period

  • Increasing awareness, high government investment, and efforts to store genetically diverse cord blood units are the factors expected to boost the segment growth of public banking

  • Cord blood captured the largest market share in 2016 over cord tissue and placenta. Relatively easy license acquisition, affordability, and ease of storage are the factors driving the segment share.

  • Key market players include California Cryobank Stem Cell Services LLC; Cord Blood America, Inc.; StemCyte, Inc.; Norton Healthcare, Inc.; Cryo-Cell International, Inc., and Lifeforce Cryobank Sciences Inc.

Grand View Research has segmented the U.S. cord blood banking market on the basis of blood bank type, component and state:

Bank Type Outlook (Revenue, USD Billion, 2014 - 2025)

  • Private

  • Public

  • Hybrid

Component 8Outlook (Revenue, USD Billion, 2014 - 2025)

  • Cord Blood

  • Cord Tissue

  • Placenta

Regional Outlook (Revenue, USD Billion, 2014 - 2025)

  • Arizona

  • California

  • Florida

  • Kentucky

  • New Jersey

  • Texas

  • Houston

  • Massachusetts

Request Sample
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $7,950
Compass Access - $9,950

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA